DK1189912T3 - Nye krystallinske former af et makrolid antibiotikum - Google Patents
Nye krystallinske former af et makrolid antibiotikumInfo
- Publication number
- DK1189912T3 DK1189912T3 DK00914336T DK00914336T DK1189912T3 DK 1189912 T3 DK1189912 T3 DK 1189912T3 DK 00914336 T DK00914336 T DK 00914336T DK 00914336 T DK00914336 T DK 00914336T DK 1189912 T3 DK1189912 T3 DK 1189912T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystalline forms
- new crystalline
- macrolide antibiotic
- macrolide
- antibiotic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13464499P | 1999-05-18 | 1999-05-18 | |
| PCT/IB2000/000463 WO2000069874A1 (en) | 1999-05-18 | 2000-04-14 | Novel crystalline forms of a macrolide antibiotic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1189912T3 true DK1189912T3 (da) | 2008-06-30 |
Family
ID=22464300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00914336T DK1189912T3 (da) | 1999-05-18 | 2000-04-14 | Nye krystallinske former af et makrolid antibiotikum |
Country Status (43)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465437B1 (en) * | 1999-06-30 | 2002-10-15 | Pfizer Inc. | Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition |
| MXPA02007305A (es) | 2000-01-27 | 2002-11-29 | Pfizer Prod Inc | Composiciones antiboticas de azalida. |
| JP4104463B2 (ja) * | 2001-04-27 | 2008-06-18 | ファイザー・プロダクツ・インク | ４’’−置換された−９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシン誘導体を製造するための方法 |
| EP1435359A1 (en) * | 2002-12-31 | 2004-07-07 | Alembic Limited | A process for the purification of roxithromycin |
| US7384921B2 (en) * | 2004-02-20 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | Polymorphic forms of 6-11 bicyclic ketolide derivatives |
| MA32997B1 (fr) * | 2009-01-30 | 2012-01-02 | Glaxo Group Ltd | Macrolide anti-inflammatoire |
| EP2402355A1 (en) * | 2010-07-01 | 2012-01-04 | Novartis AG | Crystalline anhydrous forms II and III of Tulathromycin |
| WO2013013834A1 (en) | 2011-07-27 | 2013-01-31 | Farma Grs, D.O.O. | New crystalline forms of tulathromycin |
| CN106008622A (zh) * | 2016-08-02 | 2016-10-12 | 海门慧聚药业有限公司 | 泰拉霉素新晶型及其制备 |
| CN109942652B (zh) * | 2017-12-21 | 2022-04-26 | 洛阳惠中兽药有限公司 | 一种莱柯霉素晶型ⅰ及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO107257B1 (ro) * | 1987-07-09 | 1993-10-30 | Pfizer | Procedeu de obtinere a unui dihidrat de azitromicina, cristalin |
| US5441939A (en) * | 1994-03-04 | 1995-08-15 | Pfizer Inc. | 3"-desmethoxy derivatives of erythromycin and azithromycin |
| US5844105A (en) * | 1996-07-29 | 1998-12-01 | Abbott Laboratories | Preparation of crystal form II of clarithromycin |
| HN1998000086A (es) * | 1997-06-11 | 1999-03-08 | Pfizer Prod Inc | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. |
-
2000
- 2000-04-14 IL IL14594600A patent/IL145946A0/xx active IP Right Grant
- 2000-04-14 CZ CZ20014120A patent/CZ20014120A3/cs unknown
- 2000-04-14 WO PCT/IB2000/000463 patent/WO2000069874A1/en active IP Right Grant
- 2000-04-14 JP JP2000618290A patent/JP3897983B2/ja not_active Expired - Fee Related
- 2000-04-14 HU HU0201341A patent/HUP0201341A3/hu unknown
- 2000-04-14 DK DK00914336T patent/DK1189912T3/da active
- 2000-04-14 PT PT00914336T patent/PT1189912E/pt unknown
- 2000-04-14 EA EA200100984A patent/EA003417B1/ru not_active IP Right Cessation
- 2000-04-14 AU AU35729/00A patent/AU772283B2/en not_active Ceased
- 2000-04-14 CN CNB008077029A patent/CN1203084C/zh not_active Expired - Fee Related
- 2000-04-14 EP EP00914336A patent/EP1189912B1/en not_active Expired - Lifetime
- 2000-04-14 UA UA2001117852A patent/UA67842C2/uk unknown
- 2000-04-14 CA CA002372206A patent/CA2372206C/en not_active Expired - Lifetime
- 2000-04-14 KR KR10-2001-7014687A patent/KR100474229B1/ko not_active IP Right Cessation
- 2000-04-14 OA OA1200100283A patent/OA11876A/en unknown
- 2000-04-14 PL PL00353316A patent/PL353316A1/xx unknown
- 2000-04-14 DE DE60038610T patent/DE60038610T2/de not_active Expired - Lifetime
- 2000-04-14 BR BR0011300-0A patent/BR0011300A/pt not_active Application Discontinuation
- 2000-04-14 AP APAP/P/2001/002325A patent/AP2001002325A0/en unknown
- 2000-04-14 NZ NZ514765A patent/NZ514765A/en unknown
- 2000-04-14 MX MXPA01011914A patent/MXPA01011914A/es active IP Right Grant
- 2000-04-14 YU YU76601A patent/YU76601A/sh unknown
- 2000-04-14 ES ES00914336T patent/ES2302689T3/es not_active Expired - Lifetime
- 2000-04-14 SK SK1647-2001A patent/SK16472001A3/sk unknown
- 2000-04-14 AT AT00914336T patent/ATE392427T1/de not_active IP Right Cessation
- 2000-04-25 HN HN2000000056A patent/HN2000000056A/es unknown
- 2000-05-02 US US09/563,792 patent/US6583274B1/en not_active Expired - Lifetime
- 2000-05-05 PA PA20008495001A patent/PA8495001A1/es unknown
- 2000-05-12 TW TW089109175A patent/TWI225066B/zh not_active IP Right Cessation
- 2000-05-15 UY UY26144A patent/UY26144A1/es not_active Application Discontinuation
- 2000-05-15 MY MYPI20002125A patent/MY133397A/en unknown
- 2000-05-16 AR ARP000102353A patent/AR020030A1/es not_active Application Discontinuation
- 2000-05-16 PE PE2000000459A patent/PE20010151A1/es not_active Application Discontinuation
- 2000-05-17 DZ DZ000086A patent/DZ3043A1/xx active
- 2000-05-17 GT GT200000072A patent/GT200000072A/es unknown
- 2000-05-17 MA MA25979A patent/MA26735A1/fr unknown
- 2000-05-17 TN TNTNSN00103A patent/TNSN00103A1/fr unknown
-
2001
- 2001-10-15 IL IL145946A patent/IL145946A/en unknown
- 2001-10-26 IS IS6127A patent/IS6127A/is unknown
- 2001-11-15 ZA ZA200109420A patent/ZA200109420B/xx unknown
- 2001-11-16 HR HR20010849A patent/HRP20010849A2/hr not_active Application Discontinuation
- 2001-11-16 NO NO20015598A patent/NO320195B1/no unknown
- 2001-11-26 BG BG106150A patent/BG106150A/bg unknown
-
2002
- 2002-09-26 HK HK02107017.2A patent/HK1045521B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE345350T1 (de) | Makrolidantibiotika | |
| DK1064942T3 (da) | Sustained release-fremstilling af et makrolid | |
| NO20020814D0 (no) | Nye spiroforbindelser | |
| NO20003347L (no) | Nye makrolider | |
| NO20003346D0 (no) | Nye erytromycinderivater | |
| NO20012155D0 (no) | Nye makrolid-antibiotika | |
| DK1169314T3 (da) | Krystallinsk base af citalopram | |
| DE60008545D1 (de) | Antibakterielle heterobicyclisch substituierte phenyloxazolidinone | |
| NO20010916L (no) | Nye antibakterielle isoksazolinoner | |
| DK1107980T3 (da) | Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH | |
| NO20020810L (no) | Nye fenylpiperaziner | |
| DK1189912T3 (da) | Nye krystallinske former af et makrolid antibiotikum | |
| NO20020030L (no) | Krystallinske 1-metylkarbapenemforbindelser | |
| NO20014362D0 (no) | Erytromycinderivater | |
| NO20006255L (no) | Krystallinsk efavirenz | |
| NO20024527L (no) | Krystallinsk form II av kabergolin | |
| DK1196431T3 (da) | En i det væsentlige krystallinsk form af melagatran | |
| ID26418A (id) | METODA KRISTALISASI ANTIBIOTIK β-LAKTAM | |
| IS5821A (is) | Kristalluð form af ósanetant | |
| DK1246827T3 (da) | Nye polymorfe former af olanzapin | |
| DK1311296T3 (da) | Oplösning af et antibiotisk oxazolidinon-lægemiddel | |
| NO20024679L (no) | Krystallinsk farmasöytikum | |
| NO20030416L (no) | Krystallinsk terapeutisk forbindelse | |
| DK1228078T3 (da) | Fremstilling af en makrocyklisk lakton | |
| SE0001422D0 (sv) | Crystalline form |